Intrinsiqq
Inhibikase Therapeutics Inc. logo

Inhibikase Therapeutics Inc. Intrinsic Value

IKT

Compare

Inhibikase Therapeutics fair value

None of the figures this calculator works from (earnings, free cash flow, revenue, book value, dividends) is positive for Inhibikase Therapeutics today, so there is nothing to project yet.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with IKT

CompareIntrinsic value
CVMCel-Sci Corporation
$1.21-17.69%0
ARTVArtiva Biotherapeutics Inc.
$3.78-1.31%10
BCABBioAtla, Inc.
$1.55+20.16%0
ZIVOZivo Bioscience Inc.
$5.50+0.00%0
WINTWindtree Therapeutics Inc.
$0.00-33.33%10
ATYRAtyr Pharma Inc.
$3.82+3.52%10
ARMPArmata Pharmaceuticals Inc.
$3.03+1.68%30
VIVSVivoSim Labs, Inc.
$0.26-10.34%10

Held by ETFs

IKT is in 3 US ETFs. The largest of them, with IKT's weight in each:

Spot a number that looks wrong? Check it in IKT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing IKT

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.